AdipoRon Alleviates Free Fatty Acid-Induced Myocardial Cell Injury Via Suppressing Nlrp3 Inflammasome Activation

References

• Hubert HB , Feinleib M , McNamara PM , Castelli WP . Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation . 1983;67:968–977. doi:10.1161/01.cir.67.5.968 6219830
   PubMed Web of Science ®Google Scholar
• Goldberg IJ , Trent CM , Schulze PC . Lipid metabolism and toxicity in the heart. Cell Metab . 2012;15:805–812. doi:10.1016/j.cmet.2012.04.006 22682221
   PubMed Web of Science ®Google Scholar
• Kim JK , Fillmore JJ , Sunshine MJ , et al. PKC-theta knockout mice are protected from fat-induced insulin resistance. J Clin Invest . 2004;114:823–827. doi:10.1172/JCI22230 15372106
   PubMed Web of Science ®Google Scholar
• Ganesan V , Perera MN , Colombini D , Datskovskiy D , Chadha K , Colombini M . Ceramide and activated Bax act synergistically to permeabilize the mitochondrial outer membrane. Apoptosis . 2010;15:553–562. doi:10.1007/s10495-009-0449-0 20101465
   PubMed Web of Science ®Google Scholar
• Park M , Sabetski A , Kwan Chan Y , Turdi S , Sweeney G . Palmitate induces ER stress and autophagy in H9c2 cells: implications for apoptosis and adiponectin resistance. J Cell Physiol . 2015;230:630–639. doi:10.1002/jcp.24781 25164368
   PubMed Web of Science ®Google Scholar
• Martinon F , Burns K , Tschopp J . The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell . 2002;10:417–426. doi:10.1016/s1097-2765(02)00599-3 12191486
   PubMed Web of Science ®Google Scholar
• Vandanmagsar B , Youm YH , Ravussin A , et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med . 2011;17:179–188. doi:10.1038/nm.2279 21217695
   PubMed Web of Science ®Google Scholar
• Wen H , Gris D , Lei Y , et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol . 2011;12:408–415. doi:10.1038/ni.2022 21478880
   PubMed Web of Science ®Google Scholar
• Chen Y , Pitzer AL , Li X , Li PL , Wang L , Zhang Y . Instigation of endothelial Nlrp3 inflammasome by adipokine visfatin promotes inter-endothelial junction disruption: role of HMGB1. J Cell Mol Med . 2015;19:2715–2727. doi:10.1111/jcmm.12657 26293846
   PubMed Web of Science ®Google Scholar
• Zhang Y , Li X , Pitzer AL , Chen Y , Wang L , Li PL . Coronary endothelial dysfunction induced by nucleotide oligomerization domain-like receptor protein with pyrin domain containing 3 inflammasome activation during hypercholesterolemia: beyond inflammation. Antioxid Redox Signal . 2015;22:1084–1096. doi:10.1089/ars.2014.5978 25739025
   PubMed Web of Science ®Google Scholar
• Wang L , Chen Y , Li X , Zhang Y , Gulbins E , Zhang Y . Enhancement of endothelial permeability by free fatty acid through lysosomal cathepsin B-mediated Nlrp3 inflammasome activation. Oncotarget . 2016;7:73229–73241. doi:10.18632/oncotarget.12302 27689324
   PubMedGoogle Scholar
• Mangali S , Bhat A , Udumula MP , Dhar I , Sriram D , Dhar A . Inhibition of protein kinase R protects against palmitic acid-induced inflammation, oxidative stress, and apoptosis through the JNK/NF-kB/NLRP3 pathway in cultured H9C2 cardiomyocytes. J Cell Biochem . 2019;120:3651–3663. doi:10.1002/jcb.27643 30259999
   PubMed Web of Science ®Google Scholar
• Hotta K , Funahashi T , Bodkin NL , et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes . 2001;50:1126–1133. doi:10.2337/diabetes.50.5.1126 11334417
   PubMed Web of Science ®Google Scholar
• Menzaghi C , Trischitta V . The adiponectin paradox for all-cause and cardiovascular mortality. Diabetes . 2018;67:12–22. doi:10.2337/dbi17-0016 29263167
   PubMed Web of Science ®Google Scholar
• Shibata R , Sato K , Pimentel DR , et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med . 2005;11:1096–1103. doi:10.1038/nm1295 16155579
   PubMed Web of Science ®Google Scholar
• Tao L , Gao E , Jiao X , et al. Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation . 2007;115:1408–1416. doi:10.1161/CIRCULATIONAHA.106.666941 17339545
   PubMed Web of Science ®Google Scholar
• Goldstein BJ , Scalia RG , Ma XL . Protective vascular and myocardial effects of adiponectin. Nat Clin Pract Cardiovasc Med . 2009;6:27–35. doi:10.1038/ncpcardio1398 19029992
   PubMedGoogle Scholar
• Okada-Iwabu M , Yamauchi T , Iwabu M , et al. A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity. Nature . 2013;503:493–499. doi:10.1038/nature12656 24172895
   PubMed Web of Science ®Google Scholar
• Zhang Y , Zhao J , Li R , et al. AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings. Am J Physiol Endocrinol Metab . 2015;309:E275–E282. doi:10.1152/ajpendo.00577.2014 26037251
   PubMed Web of Science ®Google Scholar
• Hu X , Ou-Yang Q , Wang L , Li T , Xie X , Liu J . AdipoRon prevents l-thyroxine or isoproterenol-induced cardiac hypertrophy through regulating the AMPK-related pathway. Acta Biochim Biophys Sin (Shanghai) . 2019;51:20–30. doi:10.1093/abbs/gmy152 30566571
   PubMed Web of Science ®Google Scholar
• Fairaq A , Shawky NM , Osman I , Pichavaram P , Segar L . AdipoRon, an adiponectin receptor agonist, attenuates PDGF-induced VSMC proliferation through inhibition of mTOR signaling independent of AMPK: implications toward suppression of neointimal hyperplasia. Pharmacol Res . 2017;119:289–302. doi:10.1016/j.phrs.2017.02.016 28237515
   PubMed Web of Science ®Google Scholar
• Choi SR , Lim JH , Kim MY , et al. Adiponectin receptor agonist AdipoRon decreased ceramide, and lipotoxicity, and ameliorated diabetic nephropathy. Metabolism . 2018;85:348–360. doi:10.1016/j.metabol.2018.02.004 29462574
   PubMed Web of Science ®Google Scholar
• Vasiliauskaite-Brooks I , Sounier R , Rochaix P , et al. Structural insights into adiponectin receptors suggest ceramidase activity. Nature . 2017;544:120–123. doi:10.1038/nature21714 28329765
   PubMed Web of Science ®Google Scholar
• Boden G . Interaction between free fatty acids and glucose metabolism. Curr Opin Clin Nutr Metab Care . 2002;5:545–549.12172479
   PubMed Web of Science ®Google Scholar
• Kim Y , Lim JH , Kim MY , et al. The adiponectin receptor agonist AdipoRon ameliorates diabetic nephropathy in a model of type 2 diabetes. J Am Soc Nephrol . 2018;29:1108–1127. doi:10.1681/ASN.2017060627 29330340
   PubMed Web of Science ®Google Scholar
• Zhang J , Xia L , Zhang F , et al. A novel mechanism of diabetic vascular endothelial dysfunction: hypoadiponectinemia-induced NLRP3 inflammasome activation. Biochim Biophys Acta . 2017;1863:1556–1567. doi:10.1016/j.bbadis.2017.02.012
   Web of Science ®Google Scholar
• Shi H , Kokoeva MV , Inouye K , Tzameli I , Yin H , Flier JS . TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest . 2006;116:3015–3025. doi:10.1172/JCI28898 17053832
   PubMed Web of Science ®Google Scholar
• Mariathasan S , Weiss DS , Newton K , et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature . 2006;440:228–232. doi:10.1038/nature04515 16407890
   PubMed Web of Science ®Google Scholar
• Lamkanfi M . Emerging inflammasome effector mechanisms. Nat Rev Immunol . 2011;11:213–220. doi:10.1038/nri2936 21350580
   PubMed Web of Science ®Google Scholar
• Zhou R , Yazdi AS , Menu P , Tschopp J . A role for mitochondria in NLRP3 inflammasome activation. Nature . 2011;469:221–225. doi:10.1038/nature09663 21124315
   PubMed Web of Science ®Google Scholar
• Chen Y , Wang L , Pitzer AL , Li X , Li PL , Zhang Y . Contribution of redox-dependent activation of endothelial Nlrp3 inflammasomes to hyperglycemia-induced endothelial dysfunction. J Mol Med (Berl) . 2016;94:1335–1347. doi:10.1007/s00109-016-1481-5 27783111
   PubMed Web of Science ®Google Scholar
• Liu Y , Lian K , Zhang L , et al. TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury. Basic Res Cardiol . 2014;109:415. doi:10.1007/s00395-014-0415-z 25015733
   PubMed Web of Science ®Google Scholar
• Satoh T , Kambe N , Matsue H . NLRP3 activation induces ASC-dependent programmed necrotic cell death, which leads to neutrophilic inflammation. Cell Death Dis . 2013;4:e644. doi:10.1038/cddis.2013.169 23703389
   PubMed Web of Science ®Google Scholar